en

PRODUCT DETAIL

Ryeqo 40 mg/1 mg/0,5 mg filmom obalené tablety

Code 5612E
MA number EU/1/21/1565/004
Product Form: tbl flm 84x40 mg/1 mg/0,5 mg (blis.PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
ATC:
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01C HYPOTHALAMIC HORMONES
H01CC Anti-gonadotropin-releasing hormones
H01CC54 Relugolix, estradiol and norethisterone
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 16.07.2021
Validity: 16.07.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 21.02.2024
eu-flag.png sk-flag.png